Fig. 6From: Plasma proteomic characterization of colorectal cancer patients with FOLFOX chemotherapy by integrated proteomics technologyPRM validation. A Transitions of peptide GWVTDGFSSLK selected for quantification. B Quantification of peptide GWVTDGFSSLK. Each color presents a transition ion and corresponding bar graph presents peak area values. C Protein Abundance comparison across 26 validated samples including 13 SENS and 13 NONE group samples respectivelyBack to article page